More articles from MTA I: Radiopharmaceutical Therapy Posters

You have access
Effectiveness of Rhenium-188 HEDP for management of metastatic bone pain in patients with prostate cancer: A clinical trial
Augusto Llamas, Carmen de los Reyes, Carlos Rodriguez, Rodolfo Varela, Andres Munar and Juan Castillo

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1406;
You have access
Labeling anti-epidermal growth factor receptor variant three monoclonal antibody CH12 with 131I to treatment gliomas: In vitro and in vivo
Wang Lili and Li Peiyong

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1371;
You have access
Long term toxicity studies of ¹⁷⁷Lu-tetraxetan-tetulomab in nude mice
Ada Repetto-Llamazares, Camilla Mollatt, Roy Larsen, Anna Giusti, Elena Riccardi and Jostein Dahle

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1370;
You have access
Survival and adverse events after radioembolization of liver metastases from colorectal cancer using glass or resin based yttrium-90 microspheres
Andrei Purysko, Sankaran Shrikanthan and Shyam Srinivas

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1385;
You have access
Labeling, purification, formulation and in vivo evaluation of radioiodinated hypericin as a theragnostic agent for a new anticancer strategy
Marlein Miranda Cona, Junjie Li, Yuanbo Feng, Feng Chen, Alfons Verbruggen, Peter de Witte, Raymond Oyen and Yicheng Ni

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1403;
You have access
Intratumoral positron emission cancer therapy (IPECT) using F-18 FDG, Cu-64 Cl and Ga-68 Cl
Franklin Wong, Katherine Naff, Chengwen Liu, Adrienne Ferguson and Patrick Hwu

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1400;
You have access
Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma
Wan Yu Lin and Tsai-Yueh Luo

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1393;
You have access
The relevance of uptake values using [68Ga]-DOTATATE PET in patients with metastasized neuroendocrine tumors for the prediction of delivered tumor doses after PRRT
Harun Ilhan, Andreas Delker, Christian Zach, Guido Böning, Peter Bartenstein, Marcus Hacker and Alexander Haug

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1379;
You have access
Do we really have to be cautious of repeating the Y-90-EDTMP therapy for bone pain palliation?
Ildiko Balogh, Zoltán Galler and László Landherr

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1405;
You have access
Radioimmunotherapy for small cell lung cancer utilizing newly developed Y-90 labeled anti-ROBO1 antibody
Keitaro Koyama, Kentaro Fujiwara, Takayuki Kitada, Miwako Takahashi and Toshimitsu Momose

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1369;

Main menu

User menu

Search

More articles from MTA I: Radiopharmaceutical Therapy Posters

Pages